We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Joseph Antin

Joseph H Antin MD

Chief Emeritus of the Stem Cell Transplant Program of the Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA

Dr. Antin received his BA degree from Williams College in 1974 and followed with an MD from Cornell University in 1978. His fellowship training in Hematology and Medical Oncology were undertaken at Brigham and Women's Hospital and Dana-Farber Cancer Institute. He served as director of the Bone Marrow Transplantation Service at Brigham and Women’s Hospital from 1987 to 1997. From 1997 he was Chief of the Stem Cell Transplant Program of the Dana-Farber/Brigham and Women’s Cancer Center – he is now Chief Emeritus. He is a founding member and past president of the American Society of Blood and Marrow Transplantation and a past Chairman of the Steering Committee of the BMT Clinical Trials Network. He has served on several committees for the American Society of Hematology. He is a member of the American Society for Clinical Investigation, and the American Association of Physicians, and a Fellow of the American Association for the Advancement of Science. He has trained numerous faculty members and fellows, many of whom are national and regional leaders in stem cell transplantation. Dr Antin has a specific interest in Graft-v-Host disease, aplastic anemia and congenital bone marrow disorders that manifest in adulthood. He has published over 400 scientific articles, chapters, and reviews.

 

Recent Contributions to PracticeUpdate:

  1. Role of Donor Clonal Hematopoiesis in Allogeneic HSCT